Jessica Elizabeth Haberer MD

Physician

Education & Training

University of California (San Francisco)Residency, Internal Medicine, 1999 - 2002
Yale School of MedicineClass of 1999

PubMed

Subtypes A1 and D, and recombinant HIV-1 natural polymorphisms associated with lenacapavir drug resistance in Uganda.
Daniel Omoding, Nicholas Musinguzi, Yap Boum 2nd, Conrad Muzoora, Simone Kigozi
The Journal of Antimicrobial Chemotherapy. 2025-04-02
Use of tenofovir-based preexposure prophylaxis among pregnant women in South Africa.
Lynn T Matthews, Katia J Bruxvoort, Manjeetha Jaggernath, Yolandie Kriel, Patricia M Smith
AIDS. 2025-04-01
1 citations
Longitudinal Changes in Tenofovir and Tenofovir Diphosphate Concentrations Among Pregnant Women Using Oral PrEP for HIV Prevention: Findings From Durban, South Africa.
Ivana Beesham, Manjeetha Jaggernath, Yolandie Kriel, Jiaying Hao, Patricia M Smith
Journal of Acquired Immune Deficiency Syndromes. 2025-04-01

Journal Articles

Short Message Service (SMS) Surveys Assessing Pre-Exposure Prophylaxis (PrEP) Adherence and Sexual Behavior Are Highly Acceptable Among HIV-Uninfected Members of Serod...
Jared M Baeten, Jessica E Haberer, AIDS and Behavior
Feasibility and Acceptability of Real-Time Antiretroviral Adherence Monitoring Among Depressed Women Living with HIV in the Deep South of the US
Christina Psaros, Jessica E Haberer, AIDS and Behavior
Patterns of Oral PrEP Adherence and HIV Risk Among Eastern African Women in HIV Serodiscordant Partnerships
Elizabeth R Brown, Jessica E Haberer, Connie Celum, Jared M Baeten, AIDS and Behavior
Depression and Suicidal Ideation Among HIV-Infected Adults Receiving Efavirenz Versus Nevirapine in Uganda: A Prospective Cohort Study
Jeffrey N Martin, David R Bangsberg, Peter W Hunt, Jessica E Haberer, Annals of Internal Medicine
Ugandan Study Participants Experience Electronic Monitoring of Antiretroviral Therapy Adherence as Welcomed Pressure to Adhere
Jessica E Haberer, Jeffrey I Campbell, AIDS and Behavior
Join now to see all

African Studies Explore Reasons to Start, Stick with or Stop PrEPFebruary 8th, 2021
African PrEP Studies Explore Reasons to Start, Stick with or StopFebruary 8th, 2021
How a Global Partnership Could Save the Lives of Women and Children in AfricaMay 2nd, 2019
Join now to see all

PrEP My Way: A hybrid type 1 clinical effectiveness-implementation trial to promote PrEP persistence among young Kenyan womenMASSACHUSETTS GENERAL HOSPITAL2024–2029
Drug concentration measurement for HIV prevention targets: toward a population-based HIV impact assessment (PHIA) for PrEPNEW YORK UNIVERSITY SCHOOL OF MEDICINE2024–2028
Research Training in Global Non-Communicable DiseasesMASSACHUSETTS GENERAL HOSPITAL2023–2028
MUST Data Science Research Hub (MUDSReH)MBARARA UNIVERSITY/SCIENCE/ TECHNOLOGY2021–2026
MUST Data Science Research Hub (MUDSReH)MBARARA UNIVERSITY/SCIENCE/ TECHNOLOGY2021–2026
Use of sentiment analysis in SMS and social media to understand HIV prevention needs among young women in KenyaMASSACHUSETTS GENERAL HOSPITAL2023–2025
Use of sentiment analysis in SMS and social media to understand HIV prevention needs among young women in KenyaMASSACHUSETTS GENERAL HOSPITAL2023–2025
Fostering diversity in the next generation of HIV researchers to improve the HIV continuum of careMASSACHUSETTS GENERAL HOSPITAL2020–2025
Novel Measures And Theory Of Pediatric Antiretroviral Therapy Adherence In UgandaNational Institute Of Mental Health2009–2011
Measurement Of Adherence To ART In Hiv-Infected School-Aged Children In UgandaNational Institute Of Mental Health2009
Measurement Of Adherence To ART In Hiv-Infected School-Aged Children In UgandaNational Institute Of Mental Health2008